Expression Of Protein Kinase Eml4-Alk Gene In Non-Small Cell Lung Cancer In Fundacion Valle Del Lili, A University Hospital Of Reference In Latin America
Between 2-5% of patients with Non-Small Cell Lung Cancer (NSCLC), younger tan 50 years, present ALK (Anaplastic Lymphoma Kinase) and EML4 (Echinoderm Microtubule-associated protein Like 4) gene fusions causing inversion in chromosome2.
- Autores:
-
Fernández, Liliana
Restrepo, Juan G.
Muñoz, Carlos A.
Sua, Luz F.
- Tipo de recurso:
- Informe
- Fecha de publicación:
- 2016
- Institución:
- Universidad ICESI
- Repositorio:
- Repositorio ICESI
- Idioma:
- eng
- OAI Identifier:
- oai:repository.icesi.edu.co:10906/81357
- Acceso en línea:
- http://nebulosa.icesi.edu.co:2143/full_record.do?product=WOS&search_mode=GeneralSearch&qid=9&SID=3Dr7QVLgmeqIWKgWekv&page=1&doc=1
http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2016.193.1_MeetingAbstracts.A2588
http://hdl.handle.net/10906/81357
- Palabra clave:
- Ciencias socio biomédicas
Cáncer de pulmón
Quinasas
Fundación Valle del Lili
Medical sciences
- Rights
- openAccess
- License
- http://purl.org/coar/access_right/c_abf2
Summary: | Between 2-5% of patients with Non-Small Cell Lung Cancer (NSCLC), younger tan 50 years, present ALK (Anaplastic Lymphoma Kinase) and EML4 (Echinoderm Microtubule-associated protein Like 4) gene fusions causing inversion in chromosome2. |
---|